Log in to save to my catalogue

Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and re...

Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2828307211

Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review

About this item

Full title

Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review

Publisher

BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd

Journal title

British journal of ophthalmology, 2023-07, Vol.107 (7), p.901-905

Language

English

Formats

Publication information

Publisher

BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Background/aimsChimeric antigen receptor T-cell (CAR T) therapy has been shown to improve the remission rate and survival for patients with refractory haematological malignancies. The aim of this study is to describe ocular adverse effects associated with CAR T therapy in patients with haematological malignancies.MethodsThis is a retrospective, sin...

Alternative Titles

Full title

Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2828307211

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2828307211

Other Identifiers

ISSN

0007-1161

E-ISSN

1468-2079

DOI

10.1136/bjophthalmol-2021-320814

How to access this item